Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07050147Not ApplicableCompleted

Sonographic Evaluation of Diaphragmatic Function Under Nasal High-flow (NHF) and Non-invasive Ventilation (NIV) in Respiratory Insufficiency

Role: lead

NCT04969237Completed

Vitamine D in Post-COVID Patients

Role: lead

NCT02820675Not ApplicableCompleted

Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions

Role: collaborator

NCT03977688Completed

Evaluating a CytoSorb Score in Septic Shock

Role: lead

All 4 trials loaded